Neuropeptide Y immunoreactive neurons in murine trisomy 16 cortical cultures
- 18 Downloads
Neuropeptide Y (NPY)-containing neurons are depleted in the cortices of individuals with Alzheimer disease (AD), yet spared in the striatum of patients with Huntington chorea. It is unknown whether this neuronal phenotype is inherently susceptible to the neurodegenerative processes that are a hallmark of AD. To study this question, the murine trisomy 16 model of Down syndrome and Alzheimer disease was investigated. Since trisomic fetuses diein utero, studies were carried out on primary cultures of dissociated cortical neurons. These were prepared from 15-d gestational trisomy 16 fetuses and their littermate euploid controls, and examined by immunocytochemical staining for neuropeptide Y at 7 and 12 d in vitro. Trisomy 16 neurons were also grown on euploid glial carpets, whereas euploid neurons were grown on trisomic glia. The results demonstrate a significant increase in the number of NPY neurons and a stunting in the dendritic arbor of these neurons in trisomic vs euploid cortex. Both of these parameters could be normalized by direct contact with euploid glia. When euploid cortex was plated on trisomic glia, the number of NPY neurons and their morphology were altered so that they began to resemble trisomic NPY cortical neurons. These results indicate a dysregulation of NPY neuronal expression and differentiation in trisomy 16 cortex that are modifiable by interaction with euploid glia and imply an abnormal trophic (glial) environment in trisomic cortex.
Index EntriesNeuropeptide Y tissue culture cerebral cortex immunocytochemistry glia aneuploidy trisomy 16 Down syndrome Alzheimer disease
Unable to display preview. Download preview PDF.
- Cheng S. V., Nadeau J. H., Tanzi R. E., Watkins P. C., Jagadesh J., Taylor B. A., Haines J. L., Sacchi N., and Gusella J. F. (1988) Comparative mapping of DNA markers from familial Alzheimer’s disease and Down syndrome region of human chromosome 21 to mouse chromosomes 16 and 17.Proc. Natl. Acad. Sci. USA 85, 6032–6036.PubMedCrossRefGoogle Scholar
- Coyle J. T., Oster-Granite M. L., Reeves R., Hohmann C., Corsi P., and Gearhart J. (1991) Down Syndrome and the trisomy 16 mouse: Impact of gene imbalance on brain development and aging, inGenes, Brain and Behavior (McHugh P. R. and McKusik V. A., eds.), Raven Press, New York.Google Scholar
- Davisson M. T., Schmidt C., Reeves R. H., Irving N. G., Akeson E. C., Harris B. S., and Bronson R. T. (1993) Segmental trisomy as a mouse model for Down syndrome, inThe Phenotypic Mapping of Down Syndrome and Other Aneuploid Conditions (Epstein C. J., ed.), pp. 117–133, Wiley-Liss, New York.Google Scholar
- Epstein C. J. (1986)Consequences of Chromosome Imbalance: Principles, Mechanisms and Models. pp. 253–322, Cambridge University Press, New York.Google Scholar
- Hendry S. H. C., Jones E. G., and Emson P. C. (1984) Morphology, distribution and synaptic relations of somatostatin- and neuropeptide Y-containing neurons in rat and monkey neocortex.J. Neurosci. 4, 2407–2517.Google Scholar
- Oster-Granite M. L., Gearhart G. D., Reeves R. H., Singer H. S., Moran T. H., and Coyle J. T. (1987) Down Syndrome and the trisomy 16 mouse, inNeurology and Neurobiology, vol. 33,Animal Models of Dementia: A Synaptic Neurochemical Perspective (Coyle J. T., ed.), pp. 279–307, A. R. Liss, New York.Google Scholar
- Richards S. J., Waters J. J., Beyreuther K., Masters C. L., Wischik C. M., Sparkman D. R., White C. L., Abraham C. R., and Dunnett S. B. (1991) Transplants of mouse trisomy 16 hippocampus provide a model of Alzheimer disease related pathology.EMBO J. 2, 297–303.Google Scholar
- Unger J., Schwrtzberg M., Weindl A., and Lange W. (1986) Neuropeptide Y in the human and monkey cerebral cortex: colocalization with somatostatin.Neurosci. Lett. suppl 26, S606.Google Scholar
- Vincent S. R., Johansson O., Hokfelt T., Skirboll L., Elde R. P., Terenius L., Kimmel J., and Goldstein M. (1983) NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin and avian pancreatic polypeptide-like immunoreactivities.J. Comp. Neurol. 217, 252–263.PubMedCrossRefGoogle Scholar